CHPA Switch Strategy: Behavioral Research, Medical Community Support
This article was originally published in The Tan Sheet
Executive Summary
FDA has agreed to meet with the Consumer Healthcare Products Association to discuss the importance and relevance of conducting behavioral research to support Rx-to-OTC switch applications.
You may also be interested in...
OTC Switches Would Be Facilitated Under Direct Refill Model
Having patients receive an initial physician's diagnosis and then purchase medication OTC could be a viable way to increase the number of Rx-to-OTC switch approvals in the future, William Howard, PhD, SDM Inc., opined at a Nicholas Hall & Co. conference Feb. 7-8 in New York.
AMA "Support" For Emergency Contraceptive Switch Applications Voiced
A resolution adopted by the American Medical Association House of Delegates Dec. 5 takes a considerably more passive approach to FDA approval of OTC emergency contraceptives than the proposal originally considered.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC